Hagiwara, A.; Shuto, H.; Kudoh, R.; Omori, S.; Hiramatsu, K.; Kadota, J.-i.; Fushimi, K.; Komiya, K.
Impact of Antipseudomonal Antibiotics in Patients with Bronchiectasis Who Experienced Exacerbation or Developed Pneumonia: A Nationwide Study in Japan. Antibiotics 2024, 13, 1182.
https://doi.org/10.3390/antibiotics13121182
AMA Style
Hagiwara A, Shuto H, Kudoh R, Omori S, Hiramatsu K, Kadota J-i, Fushimi K, Komiya K.
Impact of Antipseudomonal Antibiotics in Patients with Bronchiectasis Who Experienced Exacerbation or Developed Pneumonia: A Nationwide Study in Japan. Antibiotics. 2024; 13(12):1182.
https://doi.org/10.3390/antibiotics13121182
Chicago/Turabian Style
Hagiwara, Akihiko, Hisayuki Shuto, Ryohei Kudoh, Shota Omori, Kazufumi Hiramatsu, Jun-ichi Kadota, Kiyohide Fushimi, and Kosaku Komiya.
2024. "Impact of Antipseudomonal Antibiotics in Patients with Bronchiectasis Who Experienced Exacerbation or Developed Pneumonia: A Nationwide Study in Japan" Antibiotics 13, no. 12: 1182.
https://doi.org/10.3390/antibiotics13121182
APA Style
Hagiwara, A., Shuto, H., Kudoh, R., Omori, S., Hiramatsu, K., Kadota, J.-i., Fushimi, K., & Komiya, K.
(2024). Impact of Antipseudomonal Antibiotics in Patients with Bronchiectasis Who Experienced Exacerbation or Developed Pneumonia: A Nationwide Study in Japan. Antibiotics, 13(12), 1182.
https://doi.org/10.3390/antibiotics13121182
